ArticleJournal of hematology & oncology2020

IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer.

Chengliang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.